For the Inventor, By the Inventor

Enter inventor name

Stanford, CA, United States of America

Jennifer R Cochran

USPTO Granted Patents = 41 (Patent Applications = 32)

CIPO Patents = 5 (Patent Applications = 11)

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 135(Granted Patents)

Company Filing History:

34 out of 5,309

Leland Stanford Junior University

Xcella Biosciences, Inc.

Aravive Biologics, Inc.

Nodus Therapeutics, Inc.

5. 1 out of 8,384

Massachusetts Institute of Technology

6. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Fusion Proteins

Knottin Peptides

Microcapillary Arrays

Integrin-Binding Proteins

Cancer Treatment

Polypeptides

AXL Signaling

Tumor Therapy

Ciliary Neurotrophic Factor

Vascular Endothelial Growth Factor

Engineered Peptides

Non-Natural Amino Acids

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240882 - Fusion proteins comprising an engineered knottin peptide and uses thereof (2025-03-04),

2. 12049490 - Soluble leukemia inhibitory factor receptor polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity (2024-07-30),

3. 12024705 - Methods and systems for screening using microcapillary arrays (2024-07-02),

4. 11498952 - Fusion proteins comprising an engineered knottin peptide and uses thereof (2022-11-15),

5. 11473081 - Methods and systems for screening using microcapillary arrays (2022-10-18),

6. 11466063 - Conjugated knottin mini-proteins containing non-natural amino acids (2022-10-11),

7. 11446356 - Peptides and related compositions and methods (2022-09-20),

8. 11208462 - Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same (2021-12-28),

9. 11179441 - Ciliary neurotrophic factor receptor ligands and methods of using the same (2021-11-23),

10. 11136563 - Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy (2021-10-05),

11. 11096989 - Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein (2021-08-24),

12. 11085039 - Methods and systems for screening using microcapillary arrays (2021-08-10),

13. 10888603 - Methods of treating cancer cells expressing tumor-associated integrins (2021-01-12),

14. 10844106 - Fusion proteins comprising an engineered knottin peptide and uses thereof (2020-11-24),

15. 10765625 - Knottin-drug conjugates and methods of using the same (2020-09-08),

Title: Jennifer R Cochran - Pioneering Inventor from Stanford, CA

Introduction: Jennifer R Cochran is a highly accomplished inventor based in Stanford, CA, known for her groundbreaking work in the field of biotechnology and medical devices.

Latest Patents: Jennifer R Cochran holds several patents related to innovative drug delivery systems and biomaterials, revolutionizing the way treatments are administered and improving patient outcomes.

Career Highlights: With a distinguished career spanning over two decades, Jennifer R Cochran has been at the forefront of developing cutting-edge technologies that have the potential to transform the healthcare industry.

Collaborations: Throughout her career, Jennifer R Cochran has collaborated with leading researchers, medical professionals, and industry experts to bring her inventions from concept to reality, ensuring their practical application and impact.

Conclusion: Jennifer R Cochran's dedication to innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazing inventor in the field of biotechnology, making significant contributions to the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…